Relative expression of various cancer stem cell markers in tumor remnants from APC
mice treated with dasatinib and/or curcumin as determined by RT-PCR. Tissue was procured from our previous study where Female Min mice (5 weeks; female C57BL/6J- APCMin +/- ) were treated with dasatinib (10 mg/kg body weight) and/or curcumin (250 mg/kg body weight). The treatment was given for five consecutive days per week for 4 weeks. At the end of respective treatments, the mice were euthanized and tumor remnants were obtained as described previously . RNA isolated from the tissue was analyzed for expression of different CSCs specific markers.